Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Lenihan

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Cancer Medicine|May 13, 2021
Cardiovascular adverse events associated with BRAF versus BRAF/MEK inhibitor: Cross-sectional and longitudinal analysis using two large national registriesAvirup Guha, Prantesh Jain, Michael G Fradley, et al.
Cardio-Oncology (London, England)|January 8, 2026
Global disparities and future directions in cardio-oncology training: an international survey of cardiology trainees from the international cardio-oncology societyJames M Wilson, Joshua Lushington, Rhys Gray, et al.
European Heart Journal Open|September 22, 2025
Improvement in global longitudinal strain following plasma cell-directed therapy is associated with long-term survival among patients with AL amyloidosisKristine H Jang, Anthony F Yu, Heather Landau, et al.
Journal of Cardiac Failure|January 1, 2013
Circulating neuregulin during the transition from stage A to stage B/C heart failure in a breast cancer cohortCarrie A Geisberg, Wissam M Abdallah, Monica da Silva, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Cardiac Safety Research Consortium (CSRC): Cardiovascular Safety and Adverse Event Case Report FormsMary Elizabeth Sabol, John Finkle, Mitch Krucoff, et al.
Ecancermedicalscience|August 13, 2014
Sympathetic nervous system alterations with HER2+ antagonism: an early marker of cardiac dysfunction with breast cancer treatment?Carrie G Lenneman, Wissam M Abdallah, Holly M Smith, et al.
Current Problems in Cardiology|February 24, 2023
Real-World Efficacy of Tafamidis in Patients With Transthyretin Amyloidosis and Heart FailureAhmed Ghoneem, Ammar W Bhatti, Sumanth Khadke, et al.
Pediatric Blood & Cancer|August 27, 2017
Exercise right heart catheterization for pulmonary hypertension identified on screening echocardiography in adult survivors of childhood cancer: A report from the St. Jude Lifetime CohortGregory T Armstrong, James J Tolle, Robert Piana, et al.
Cardio-Oncology (London, England)|March 29, 2025
Addressing cardiovascular risks with a goal to prevent cardiovascular complications in patients undergoing antihormonal therapy for prostate cancerNishant P Shah, Avinash Singh, Tia Higano, et al.
Cancers|February 13, 2026
Epigenome-Wide Association Studies of Proteasome Inhibitor-Related Cardiotoxicity in Patients with Multiple MyelomaRaed Awadh Alshammari, Samuel M Rubinstein, Eric Farber-Eger, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Cancer Medicine|May 13, 2021
Cardiovascular adverse events associated with BRAF versus BRAF/MEK inhibitor: Cross-sectional and longitudinal analysis using two large national registriesAvirup Guha, Prantesh Jain, Michael G Fradley, et al.
Cardio-Oncology (London, England)|January 8, 2026
Global disparities and future directions in cardio-oncology training: an international survey of cardiology trainees from the international cardio-oncology societyJames M Wilson, Joshua Lushington, Rhys Gray, et al.
European Heart Journal Open|September 22, 2025
Improvement in global longitudinal strain following plasma cell-directed therapy is associated with long-term survival among patients with AL amyloidosisKristine H Jang, Anthony F Yu, Heather Landau, et al.
Journal of Cardiac Failure|January 1, 2013
Circulating neuregulin during the transition from stage A to stage B/C heart failure in a breast cancer cohortCarrie A Geisberg, Wissam M Abdallah, Monica da Silva, et al.
Therapeutic Innovation & Regulatory Science|September 18, 2018
Cardiac Safety Research Consortium (CSRC): Cardiovascular Safety and Adverse Event Case Report FormsMary Elizabeth Sabol, John Finkle, Mitch Krucoff, et al.
Ecancermedicalscience|August 13, 2014
Sympathetic nervous system alterations with HER2+ antagonism: an early marker of cardiac dysfunction with breast cancer treatment?Carrie G Lenneman, Wissam M Abdallah, Holly M Smith, et al.
Current Problems in Cardiology|February 24, 2023
Real-World Efficacy of Tafamidis in Patients With Transthyretin Amyloidosis and Heart FailureAhmed Ghoneem, Ammar W Bhatti, Sumanth Khadke, et al.
Pediatric Blood & Cancer|August 27, 2017
Exercise right heart catheterization for pulmonary hypertension identified on screening echocardiography in adult survivors of childhood cancer: A report from the St. Jude Lifetime CohortGregory T Armstrong, James J Tolle, Robert Piana, et al.
Cardio-Oncology (London, England)|March 29, 2025
Addressing cardiovascular risks with a goal to prevent cardiovascular complications in patients undergoing antihormonal therapy for prostate cancerNishant P Shah, Avinash Singh, Tia Higano, et al.
Cancers|February 13, 2026
Epigenome-Wide Association Studies of Proteasome Inhibitor-Related Cardiotoxicity in Patients with Multiple MyelomaRaed Awadh Alshammari, Samuel M Rubinstein, Eric Farber-Eger, et al.
Pageof 8